290 related articles for article (PubMed ID: 26352211)
21. Rare actinomycetes: a potential storehouse for novel antibiotics.
Tiwari K; Gupta RK
Crit Rev Biotechnol; 2012 Jun; 32(2):108-32. PubMed ID: 21619453
[TBL] [Abstract][Full Text] [Related]
22. Understanding and manipulating antibiotic production in actinomycetes.
Bibb MJ
Biochem Soc Trans; 2013 Dec; 41(6):1355-64. PubMed ID: 24256223
[TBL] [Abstract][Full Text] [Related]
23. The regulation of the secondary metabolism of Streptomyces: new links and experimental advances.
van Wezel GP; McDowall KJ
Nat Prod Rep; 2011 Jul; 28(7):1311-33. PubMed ID: 21611665
[TBL] [Abstract][Full Text] [Related]
24. How to translate a bioassay into a screening assay for natural products: general considerations and implementation of antimicrobial screens.
Fallarero A; Hanski L; Vuorela P
Planta Med; 2014 Sep; 80(14):1182-99. PubMed ID: 25221978
[TBL] [Abstract][Full Text] [Related]
25. Actinomycetes biosynthetic potential: how to bridge in silico and in vivo?
Rebets Y; Brötz E; Tokovenko B; Luzhetskyy A
J Ind Microbiol Biotechnol; 2014 Feb; 41(2):387-402. PubMed ID: 24127068
[TBL] [Abstract][Full Text] [Related]
26. Cracking the regulatory code of biosynthetic gene clusters as a strategy for natural product discovery.
Rigali S; Anderssen S; Naômé A; van Wezel GP
Biochem Pharmacol; 2018 Jul; 153():24-34. PubMed ID: 29309762
[TBL] [Abstract][Full Text] [Related]
27. Cryptic or Silent? The Known Unknowns, Unknown Knowns, and Unknown Unknowns of Secondary Metabolism.
Hoskisson PA; Seipke RF
mBio; 2020 Oct; 11(5):. PubMed ID: 33082252
[TBL] [Abstract][Full Text] [Related]
28. Metabolite induction via microorganism co-culture: a potential way to enhance chemical diversity for drug discovery.
Bertrand S; Bohni N; Schnee S; Schumpp O; Gindro K; Wolfender JL
Biotechnol Adv; 2014 Nov; 32(6):1180-204. PubMed ID: 24651031
[TBL] [Abstract][Full Text] [Related]
29. Direct capture and heterologous expression of Salinispora natural product genes for the biosynthesis of enterocin.
Bonet B; Teufel R; Crüsemann M; Ziemert N; Moore BS
J Nat Prod; 2015 Mar; 78(3):539-42. PubMed ID: 25382643
[TBL] [Abstract][Full Text] [Related]
30. Big effects from small changes: possible ways to explore nature's chemical diversity.
Bode HB; Bethe B; Höfs R; Zeeck A
Chembiochem; 2002 Jul; 3(7):619-27. PubMed ID: 12324995
[TBL] [Abstract][Full Text] [Related]
31. Actinomycetes: still a source of novel antibiotics.
Genilloud O
Nat Prod Rep; 2017 Oct; 34(10):1203-1232. PubMed ID: 28820533
[TBL] [Abstract][Full Text] [Related]
32. Small molecule inducers of actinobacteria natural product biosynthesis.
Alwali AY; Parkinson EI
J Ind Microbiol Biotechnol; 2023 Feb; 50(1):. PubMed ID: 37587009
[TBL] [Abstract][Full Text] [Related]
33. Pharmaceutically active secondary metabolites of marine actinobacteria.
Manivasagan P; Venkatesan J; Sivakumar K; Kim SK
Microbiol Res; 2014 Apr; 169(4):262-78. PubMed ID: 23958059
[TBL] [Abstract][Full Text] [Related]
34. Continuing hunt for endophytic actinomycetes as a source of novel biologically active metabolites.
Masand M; Jose PA; Menghani E; Jebakumar SR
World J Microbiol Biotechnol; 2015 Dec; 31(12):1863-75. PubMed ID: 26410426
[TBL] [Abstract][Full Text] [Related]
35. Heterologous expression-facilitated natural products' discovery in actinomycetes.
Xu M; Wright GD
J Ind Microbiol Biotechnol; 2019 Mar; 46(3-4):415-431. PubMed ID: 30446891
[TBL] [Abstract][Full Text] [Related]
36. David and Goliath: chemical perturbation of eukaryotes by bacteria.
Ho LK; Nodwell JR
J Ind Microbiol Biotechnol; 2016 Mar; 43(2-3):233-48. PubMed ID: 26433385
[TBL] [Abstract][Full Text] [Related]
37. Elicitation of secondary metabolism in actinomycetes.
Abdelmohsen UR; Grkovic T; Balasubramanian S; Kamel MS; Quinn RJ; Hentschel U
Biotechnol Adv; 2015 Nov; 33(6 Pt 1):798-811. PubMed ID: 26087412
[TBL] [Abstract][Full Text] [Related]
38. Marine actinomycetes as an emerging resource for the drug development pipelines.
Zotchev SB
J Biotechnol; 2012 Apr; 158(4):168-75. PubMed ID: 21683100
[TBL] [Abstract][Full Text] [Related]
39. A roadmap for natural product discovery based on large-scale genomics and metabolomics.
Doroghazi JR; Albright JC; Goering AW; Ju KS; Haines RR; Tchalukov KA; Labeda DP; Kelleher NL; Metcalf WW
Nat Chem Biol; 2014 Nov; 10(11):963-8. PubMed ID: 25262415
[TBL] [Abstract][Full Text] [Related]
40. Antibacterial Compounds from Marine Bacteria, 2010-2015.
Schinke C; Martins T; Queiroz SCN; Melo IS; Reyes FGR
J Nat Prod; 2017 Apr; 80(4):1215-1228. PubMed ID: 28362500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
